Breast Cancer (Prognostics)

DNA Analysis Superior in Determining Cancer Prognosis

Published in Women's Health Weekly, March 4th, 1996

A DNA-based sequencing technique - Sequence Based Diagnosis (SBD) - that determines the p53 gene status in primary breast cancers, yields better prognostic information than standard immunohistochemistry, according to a report from Sweden.

These results were published in the February 21, 1996, issue of the Journal of the National Cancer Institute (JNCI).

"These are important findings for women and their physicians who, every day, must make decisions about therapy," said Jonas Bergh, M.D., associate professor of oncology at University of Uppsala, Sweden, and a director of the study. "The goal of clinical research must be that we will be able to treat...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-03-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry